Genetics of Sudden Cardiac Death

Current Cardiology Reports

Volumn 17, Issue 7, 2015, Pages

  Refaat, Marwan M ^a   Hotait, Mostafa ^a   London, Barry ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Arrhythmogenic hereditary syndromes; Arrhythmogenic right ventricular cardiomyopathy dysplasia; Brugada syndrome; Cardiomyopathies; Catecholaminergic polymorphic ventricular tachycardia; Dilated cardiomyopathy; Genetics; Genome wide association studies; Hypertrophic cardiomyopathy; Long QT syndrome; Short QT syndrome; Sudden cardiac death

Indexed keywords

ACTIN; ALPHA GALACTOSIDASE; CELL PROTEIN; DESMOCOLLIN 2; DESMOGLEIN 2; DESMOPLAKIN; JUNCTOPHILIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MYBPC3 GENE; MYH7 GENE; MYOSIN BINDING PROTEIN C; MYOSIN LIGHT CHAIN 2; PLAKOGLOBIN; RYANODINE RECEPTOR 2; SARCOMERIC PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TROPOMYOSIN; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACTC GENE; ANK2 GENE; BRUGADA SYNDROME; CACNA1C GENE; CALM1 GENE; CASQ2 GENE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CELL ADHESION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; ENDURANCE TRAINING; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GENOTYPE; GLA GENE; GPD1L GENE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JPH2 GENE; KCNE1 GENE; KCNE2 GENE; KCNH2 GENE; KCNJ2 GENE; KCNQ1 GENE; LAMP2 GENE; LMNA GENE; LONG QT SYNDROME; MONOGENIC DISORDER; MYL2 GENE; MYL3 GENE; NEXT GENERATION SEQUENCING; PATHOGENESIS; PHENOTYPE; PRKAG2 GENE; QRS INTERVAL; QT INTERVAL; RBM20 GENE; REVIEW; RR INTERVAL; RYR2 GENE; SARCOMERIC GENE; SCN5A GENE; SERCA2ALPHA GENE; SHORT QT SYNDROME; SUDDEN CARDIAC DEATH; TNNI3 GENE; TNNT2 GENE; TPM1 GENE; TRDN GENE; VENTRICULAR NONCOMPACTION; COMPLICATION; DEATH, SUDDEN, CARDIAC; EPIDEMIOLOGY; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENOME-WIDE ASSOCIATION STUDY; HEALTH SURVEY; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION SYSTEM; HIGH THROUGHPUT SEQUENCING; MENDELIAN RANDOMIZATION ANALYSIS; MORTALITY; PATHOPHYSIOLOGY; PEDIGREE; PROCEDURES; UNITED STATES;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HEART CONDUCTION SYSTEM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; PEDIGREE; PHENOTYPE; POPULATION SURVEILLANCE; UNITED STATES;

EID: 84930201492     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-015-0606-8     Document Type: Review

References (43)

1. Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation. 2012;125(4):620–37.
2. Adabag AS, Luepker RV, Roger VL, et al. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010;7(4):216–25.
3. Turakhia M, Tseng ZH. Sudden cardiac death: epidemiology, mechanisms, and therapy. Curr Probl Cardiol. 2007;32(9):501–46.
4. Steinhaus DA, Vittinghoff E, Moffatt E, et al. Characteristics of sudden arrhythmic death in a diverse, urban community. Am Heart J. 2012;163(1):125–31.
5. Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis. 2008;51(3):213–28.
6. Rodriguez-Calvo MS, Brion M, Allegue C, et al. Molecular genetics of sudden cardiac death. Forensic Sci Int. 2008;182(1-3):1–12.
7. Noseworthy PA, Newton-Cheh C. Genetic determinants of sudden cardiac death. Circulation. 2008;118(18):1854–63.
8. Ho CY. Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. Circulation. 2010;122(23):2430–40.
9. Refaat M. Prognosis of apical hypertrophic cardiomyopathy. JAMA. 2007;298(17):2006.
10. Kelly M, Semsarian C. Multiple mutations in genetic cardiovascular disease a marker of disease severity? Circ Cardiovasc Genet. 2009;2:182–90.
11. Sanbe A. Dilated cardiomyopathy: a disease of the myocardium. Biol Pharm Bull. 2013;36(1):18–22.
12. McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 2013;123(1):19–26.
13. Perrin MJ, Gollob MH. The genetics of cardiac disease associated with sudden cardiac death: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn. 2012;14(5):424–36.
14. Refaat MM, Lubitz SA, Makino S, et al. Genetic variation in the alternative splicing regulator, RBM20, is associated with dilated cardiomyopathy. Heart Rhythm. 2012;9(3):390–6.
15. Chopra N, Knollmann BC. Genetics of sudden cardiac death syndromes. Curr Opin Cardiol. 2011;26(3):196–203.
16. Modi S, Krahn AD. Sudden cardiac arrest without overt heart disease. Circulation. 2011;123(25):2994–3008.
17. Napolitano C, Bloise R, Monteforte N, et al. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation. 2012;125(16):2027–34.
18. Refaat MM, Buur Steffensen A, David JP, et al. High incidence of functional ion channel abnormalities in a consecutive long QT syndrome cohort with genetic variants of unknown significance. J Am Coll Cardiol. 2014;63(12):A110–1.
19. Refaat MM, Hotait M, Tseng ZH. Utility of the exercise electrocardiogram testing in sudden cardiac death risk stratification. Ann Noninvasive Electrocardiol. 2014;19(4):311–8. This study provides a thorough description of the utility of the exercise electrocardiogram testing in sudden cardiac death risk stratification.
20. George Jr AL. Common genetic variants in sudden cardiac death. Heart Rhythm. 2009;6(11 Suppl):S3–9.
21. Splawski I, Timothy KW, Tateyama M, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 2002;297(5585):1333–6.
22. Nielsen MW, Holst AG, Olesen SP, et al. The genetic component of Brugada syndrome. Front Physiol. 2013;4:179.
23. Jellins J, Milanovic M, Taitz DJ, et al. Brugada syndrome. Hong Kong Med J. 2013;19(2):159–67.
24. Sinner MF, Pfeufer A, Perz S, et al. Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study. Europace. 2009;11(10):1338–44.
25. Letsas KP, Gavrielatos G, Efremidis M, et al. Prevalence of Brugada sign in a Greek tertiary hospital population. Europace. 2007;9(11):1077–80.
26. Holst AG, Jensen HK, Eschen O, et al. Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study. Europace. 2012;14(7):1025–9.
27. Calloe K, Refaat M, Grubb S, et al. Characterization and mechanisms of action of novel Nav1.5 channel mutations associated with Brugada syndrome. Circ Arrhythm Electrophysiol. 2013;6(1):177–84.
28. Calloe K, Refaat MM, Grubb S, et al. Characterization of 3 novel NaV1.5 channel mutations associated with the Brugada syndrome. Biophys J. 2012;102(3):540a–1.
29. London B, Michalec M, Mehdi H, et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation. 2007;116(20):2260–8.
30. Ferrero-Miliani L, Holst AG, Pehrson S, et al. Strategy for clinical evaluation and screening of sudden cardiac death relatives. Fundam Clin Pharmacol. 2010;24(5):619–35.
31. Meli AC, Refaat MM, Dura M, et al. A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium. Circ Res. 2011;109(3):281–90.
32. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: a familial cause of sudden death. Circulation. 2003;108(8):965–70.
33. Priori SG, Wilde AA, Horie M, et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace. 2013;15(10):1389–406.
34. Sotoodehnia N, Isaacs A, de Bakker PI, et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet. 2010;42(12):1068–76.
35. Bezzina CR, Pazoki R, Bardai A, et al. Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nat Genet. 2010;42(8):688–91.
36. Lim BK, Xiong D, Dorner A, et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J Clin Invest. 2008;118(8):2758–70.
37. Arking DE, Junttila MJ, Goyette P, et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet. 2011;7(6):e1002158.
38. Roberts R. A genetic basis for coronary artery disease. Trends Cardiovasc Med. 2014; Epub ahead of print.
39. Dandona S, Roberts R. The role of genetic risk factors in coronary artery disease. Curr Cardiol Rep. 2014;16(5):479.
40. Frangiskakis JM, London B. Targeting device therapy: genomics of sudden death. Heart Fail Clin. 2010;6(1):93–100.
41. Refaat M, Frangiskakis JM, Grimley S, et al. The β2-adrenergic receptor Gln27 polymorphism is associated with increased ventricular arrhythmias in patients with severe heart failure. Heart Rhythm. 2009;6(5S):S456.
42. Refaat M, Mehdi H, Halder I, et al. Variations in cardiac calcium-handling genes are associated with ventricular arrhythmias in patients with severe cardiomyopathy. Heart Rhythm. 2011;8(5S):S40–1.
43. Refaat M, Aouizerat BE, Pullinger CR, et al. Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease. Heart Rhythm. 2014;11(4):646–52. This study shows that variants in calcium handling genes might lower the threshold for arrhythmias in patients with structural heart disease.